These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6969974)

  • 41. Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.
    Male DK; Roitt IM
    Clin Exp Immunol; 1981 Dec; 46(3):521-9. PubMed ID: 7337979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of therapeutic regimens on specific classes of rheumatoid factor.
    Pope RM; Lessard J; Nunnery E
    Ann Rheum Dis; 1986 Mar; 45(3):183-9. PubMed ID: 3954468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of D-penicillamine treatment on the humoral immune system.
    Stanworth DR; Hunneyball IM
    Scand J Rheumatol Suppl; 1979; (28):37-46. PubMed ID: 287190
    [No Abstract]   [Full Text] [Related]  

  • 44. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ELISA assays for IgM and IgG rheumatoid factors: their clinical correlations during therapy with slow-acting anti-rheumatic drugs.
    Scott DL; Dawes PT; Collins M; Stone R
    Clin Rheumatol; 1987 Sep; 6(3):358-68. PubMed ID: 3127104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis.
    Pritchard MH; Nuki G
    Ann Rheum Dis; 1978 Dec; 37(6):493-503. PubMed ID: 107867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Blood serum proteins, IgA, IgG and IgM immunoglobulins and alpha 1-antitrypsin and alpha 1-antichymotrypsin in peptic ulcer treated with altramet].
    Przybyłowski J; Bartelik S; Szrajer J; Małolepszy J
    Wiad Lek; 1988 Oct; 41(20):1347-50. PubMed ID: 2907701
    [No Abstract]   [Full Text] [Related]  

  • 48. [Serum IgA, IgG and IgM in members of families of patients with rheumatoid arthritis].
    Zimmermann-Gorska I; Potocka-Michajluk U; Mackiewicz S
    Pol Arch Med Wewn; 1974 Oct; 52(4):401-8. PubMed ID: 4609311
    [No Abstract]   [Full Text] [Related]  

  • 49. Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune status.
    Zilko PJ; Dawkins RL; Cohen ML
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):118-22. PubMed ID: 122657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum IgA and gold-induced toxic effects in patients with rheumatoid arthritis.
    Van Riel PL; van de Putte LB; Gribnau FW; de Waal RM
    Arch Intern Med; 1984 Jul; 144(7):1401-3. PubMed ID: 6428342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of 19S antibodies and macroglobulin complexes from the synovial fluid in rheumatoid arthritis].
    Gay S; Geiler G
    Z Gesamte Inn Med; 1970 Jun; 25(11):496-500. PubMed ID: 5523393
    [No Abstract]   [Full Text] [Related]  

  • 54. [High levels of blood IgA in patients with rheumatoid arthritis].
    Ferlazzo B; Bonanno D; Quattrocchi P; Mazzeo L; Barrile A
    Minerva Med; 1997; 88(7-8):283-7. PubMed ID: 9304070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgA deficiency during aurothioglucose treatment. A case report.
    van Riel PL; van de Putte LB; Gribnau FW; de Waal RM
    Scand J Rheumatol; 1984; 13(4):334-6. PubMed ID: 6441247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological parameters in leprosy patients with and without arthritis.
    Pal S; Singh SB; Bhattacharya SK
    J Indian Med Assoc; 1995 Jul; 93(7):266-7. PubMed ID: 8576590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of the efficacy of surgical therapy of patients with rheumatoid arthritis on the basis of quantitative determination of immunoglobulins A,M,G in the blood serum].
    Okuneva LM
    Ortop Travmatol Protez; 1979 Jul; (7):51-2. PubMed ID: 537790
    [No Abstract]   [Full Text] [Related]  

  • 58. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
    Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
    J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
    Newkirk MM; LePage K; Niwa T; Rubin L
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Penicillamine-induced polymyositis (author's transl)].
    Bettendorf U; Neuhaus R
    Dtsch Med Wochenschr; 1974 Dec; 99(49):2513, 2522-5. PubMed ID: 4548017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.